# DiaMedica Therapeutics Inc.: Form 8-K, filed Nov 10, 2021

- Company: [DiaMedica Therapeutics Inc.](/companies/dmac.md) (CIK 1401040)
- Form: 8-K
- Filed: 2021-11-10
- Accepted by EDGAR: Nov 10, 2021, 16:34 ET
- Period: 2021-11-10
- Accession: 0001437749-21-026172
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1401040/000143774921026172/dmtp20211110_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1401040/000143774921026172/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1401040/000143774921026172/dmtp20211110_8k.htm

Filed Nov 10, 2021.
Source: SEC EDGAR, the filing index for accession 0001437749-21-026172. Last ingested by Listed: Oct 24, 2026, 15:09 ET. No prices; not investment advice.